p53-Dependent and p53-independent activation of autophagy by ARF

Wassim M Abida1, Wei Gu

  • 1Institute for Cancer Genetics and Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.

Cancer Research
|January 18, 2008
PubMed

Insights

Full-length ARF protein can trigger autophagy, a cellular degradation process, independently of p53. This discovery reveals new tumor suppression mechanisms for ARF, acting with or without p53 depending on the cell type.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The ARF tumor suppressor normally induces cell cycle arrest and apoptosis.
  • A shorter ARF isoform (smARF) can induce autophagy independently of p53.
  • The role of full-length ARF in autophagy induction remains unclear.

Purpose of the Study:

  • To investigate whether full-length ARF can induce autophagy.
  • To determine if p53 is required for ARF-mediated autophagy.
  • To elucidate the mechanisms of ARF-induced autophagy.

Main Methods:

  • Cell culture experiments using 293T cells with inactivated p53.
  • Expression of full-length ARF and its N-terminal region.
  • RNA interference (RNAi) to knock down p53 in p53-positive cells.

Main Results:

  • Full-length ARF induces autophagy in p53-deficient cells.
  • The N-terminal region of ARF alone is sufficient to activate autophagy.
  • ARF induces p53 activation and subsequent autophagy in p53-positive cells.
  • p53 knockdown partially inhibits ARF-mediated autophagy.

Conclusions:

  • Full-length ARF can induce autophagy through both p53-dependent and p53-independent pathways.
  • ARF's role in tumor suppression may involve autophagy induction.
  • These findings expand our understanding of ARF's function in cellular regulation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...